Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
 BSE Code
 500660
ISIN Demat
INE159A01016
Book Value
98.8545682
Mar.Cap(Rs.Cr)
46,727.27
P/E
55.18
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Profit And Loss
ParticularsMar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
INCOME :      
Sales Turnover 3407.253216.343217.512920.483224.683128.53
Excise Duty0.000.000.000.000.000.00
Net Sales3407.253216.343217.512920.483224.683128.53
Other Income 143.17114.961423.27217.71624.37149.56
Stock Adjustments 69.64-67.25-13.8326.1235.43-25.57
Total Income3620.063264.054626.953164.313884.483252.52
EXPENDITURE :      
Raw Materials 1358.071182.781281.911275.491343.301327.96
Power & Fuel Cost29.6429.6027.8326.0833.3627.94
Employee Cost 624.39594.99610.23616.16628.55537.20
Other Manufacturing Expenses 113.6199.05120.14110.59107.88115.19
Selling & Administrative Expenses 374.71370.30343.57242.00376.68381.32
Miscellaneous Expenses 239.1284.3285.69287.75983.19150.08
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure2739.542361.042469.382558.073472.962539.68
Operating Profit880.52903.012157.57606.24411.52712.85
Interest 1.801.811.993.536.340.55
Gross Profit878.72901.202155.58602.71405.18712.30
Depreciation69.6865.7768.1978.6082.6848.59
Profit Before Tax809.04835.432087.39524.11322.50663.71
Tax235.71246.05407.36158.67260.17192.82
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-11.36-18.37-10.497.87-47.7245.52
Reported Net Profit584.69607.751690.53357.57110.05425.36
Extraordinary Items -66.5821.0511.18-117.79-87.094.04
Adjusted Net Profit651.27586.701679.35475.36197.14421.32
Adjustment below Net Profit -21.25-17.08-11.050.00-73.62-64.12
P & L Balance brought forward828.121745.02562.71882.771177.991113.21
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 542.101524.66508.22677.62338.81296.46
P & L Balance carried down849.46811.031733.98562.71875.621177.99
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %320.00320.00900.00300.00400.00200.00
Dividend Per Share(Rs)32.0032.0090.0030.0040.0020.00
Earnings Per Share-Unit Curr34.5135.8899.7921.116.5025.11
Earnings Per Share(Adj)-Unit Curr34.5135.8899.7921.116.5025.11
Book Value-Unit Curr105.31103.48158.0688.37108.62126.47
Book Value(Adj)-Unit Curr105.31103.48158.0688.37108.62126.47
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)